Tomas Doyle

1.6k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Tomas Doyle is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Tomas Doyle has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Tomas Doyle's work include HIV Research and Treatment (7 papers), interferon and immune responses (4 papers) and Hepatitis C virus research (4 papers). Tomas Doyle is often cited by papers focused on HIV Research and Treatment (7 papers), interferon and immune responses (4 papers) and Hepatitis C virus research (4 papers). Tomas Doyle collaborates with scholars based in United Kingdom, France and Italy. Tomas Doyle's co-authors include Michael H. Malim, Caroline Goujon, Olivier Moncorgé, Anna María Geretti, William Barclay, Hélène Bauby, Reiner Schulz, Stéphane Hué, Torsten Schaller and Christopher Ward and has published in prestigious journals such as Nature, The Lancet and PLoS ONE.

In The Last Decade

Tomas Doyle

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

2013 443 citations Caroline Goujon, Olivier Moncorgé et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomas Doyle United Kingdom	11	641	525	374	291	244	14	1.1k
María Salgado Spain	20	844 1.3×	433 0.8×	542 1.4×	184 0.6×	238 1.0×	49	1.1k
Suzannah J. Rihn United States	14	476 0.7×	749 1.4×	253 0.7×	188 0.6×	209 0.9×	16	1.1k
Ji Zhou China	14	678 1.1×	578 1.1×	338 0.9×	234 0.8×	257 1.1×	22	1.1k
Bo Hejdeman Sweden	20	558 0.9×	573 1.1×	325 0.9×	287 1.0×	207 0.8×	49	1.1k
Gaurav D. Gaiha United States	15	505 0.8×	677 1.3×	598 1.6×	270 0.9×	461 1.9×	28	1.4k
Kathie Grovit‐Ferbas United States	14	894 1.4×	549 1.0×	464 1.2×	306 1.1×	228 0.9×	15	1.2k
Philip K. Ehrenberg United States	15	546 0.9×	381 0.7×	304 0.8×	143 0.5×	193 0.8×	25	841
Brigitte Boeser‐Nunnink Netherlands	18	692 1.1×	344 0.7×	395 1.1×	206 0.7×	177 0.7×	35	902
Marie-Anne Rey-Cuillé France	12	650 1.0×	427 0.8×	330 0.9×	306 1.1×	160 0.7×	16	957
Annie David France	17	864 1.3×	682 1.3×	482 1.3×	233 0.8×	246 1.0×	22	1.2k

Countries citing papers authored by Tomas Doyle

Since Specialization

Citations

This map shows the geographic impact of Tomas Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Doyle more than expected).

Fields of papers citing papers by Tomas Doyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Doyle. The network helps show where Tomas Doyle may publish in the future.

Co-authorship network of co-authors of Tomas Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Doyle. A scholar is included among the top collaborators of Tomas Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Doyle. Tomas Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Doyle, Tomas, Olivier Moncorgé, Boris Bonaventure, et al.. (2018). The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry. Nature Microbiology. 3(12). 1369–1376. 50 indexed citations

2.

Griffiths, Paul, Emily S. Rothwell, Stephanie Wilmore, et al.. (2016). Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy. PLoS ONE. 11(9). e0163722–e0163722. 31 indexed citations

3.

Doyle, Tomas. (2016). The evolving role of interferons in viral eradication strategies. Journal of Virus Eradication. 2(2). 121–123. 3 indexed citations

4.

Doyle, Tomas, David Dunn, Francesca Ceccherini‐Silberstein, et al.. (2015). Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades. Journal of Antimicrobial Chemotherapy. 70(11). 3080–3086. 53 indexed citations

5.

Doyle, Tomas, Caroline Goujon, & Michael H. Malim. (2015). HIV-1 and interferons: who's interfering with whom?. Nature Reviews Microbiology. 13(7). 403–413. 206 indexed citations

6.

Goujon, Caroline, et al.. (2015). A Triple-Arginine Motif in the Amino-Terminal Domain and Oligomerization Are Required for HIV-1 Inhibition by Human MX2. Journal of Virology. 89(8). 4676–4680. 54 indexed citations

7.

Doyle, Tomas, Colette Smith, Paola Vitiello, et al.. (2014). The importance of HIV RNA detection below 50 copies per mL in HIV-positive patients on antiretroviral therapy: an observational study. The Lancet. 383. S44–S44. 3 indexed citations

8.

Goujon, Caroline, Olivier Moncorgé, Hélène Bauby, et al.. (2014). Transfer of the Amino-Terminal Nuclear Envelope Targeting Domain of Human MX2 Converts MX1 into an HIV-1 Resistance Factor. Journal of Virology. 88(16). 9017–9026. 76 indexed citations

9.

Goujon, Caroline, Olivier Moncorgé, Hélène Bauby, et al.. (2013). Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature. 502(7472). 559–562. 443 indexed citations breakdown →

10.

Chadwick, David, Tomas Doyle, Simon Ellis, et al.. (2013). Occult hepatitis B virus coinfection in HIV‐positive African migrants to the UK: a point prevalence study. HIV Medicine. 15(3). 189–192. 11 indexed citations

11.

Doyle, Tomas & Anna María Geretti. (2011). Low-level viraemia on HAART. Current Opinion in Infectious Diseases. 25(1). 17–25. 56 indexed citations

12.

Johns, Robin, Tomas Doyle, Marc Lipman, et al.. (2010). Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report. Journal of Medical Case Reports. 4(1). 32–32. 3 indexed citations

13.

Geretti, Anna María & Tomas Doyle. (2009). Immunization for HIV-positive individuals. Current Opinion in Infectious Diseases. 23(1). 32–38. 48 indexed citations

14.

Doyle, Tomas, Sanjay Bhagani, & Kate Cwynarski. (2008). Haemophagocytic syndrome and HIV. Current Opinion in Infectious Diseases. 22(1). 1–6. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact